Bupivacaine Effectiveness and Safety in SABER Trial (BESST).
Phase of Trial: Phase III
Latest Information Update: 06 Apr 2017
At a glance
- Drugs Bupivacaine (Primary)
- Indications Postoperative pain
- Focus Pharmacokinetics; Registrational; Therapeutic Use
- Acronyms BESST
- Sponsors DURECT Corporation
- 16 May 2014 According to the DURECT corporation media release, cardiac safety data from this trial were presented at the International Anesthetic Research Society (IARS) Annual Meeting.
- 05 Jan 2012 Primary endpoint 'Additional-treatment-required---rescue-medication' has not been met.
- 05 Jan 2012 Status changed from active, no longer recruiting to completed.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History